Seeking Alpha

Though Vivus (VVUS) is still halted following the FDA's approval of Qnexa, Arena Pharmaceuticals...

Though Vivus (VVUS) is still halted following the FDA's approval of Qnexa, Arena Pharmaceuticals (ARNA) is up 11.6% AH, and Orexigen Therapeutics (OREX) is up 14.3%. Arena and Orexigen have weight-loss drugs of their own (I, II) that are awaiting FDA approval.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs